DAVITA INC. — Director's Dealing 2015

May 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2015-05-28

Reporting Person: STAFFIERI MICHAEL DAVID (COO, Kidney Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-28	Common Stock	M	35000	$41.5050	Acquired	43215	Direct
2015-05-28	Common Stock	F	17282	$84.06	Disposed	25933	Direct
2015-05-28	Common Stock	S	9050	$84.0673	Disposed	16833	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-28	Stock Appreciation Rights	$41.5050	M	35000	Disposed	2016-03-29	Common Stock (35000)	Direct

Footnotes

F1: Represents the weighted average sale price of $84.0673. The range of prices for the sale of these shares was $84.05 - $84.11, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: Stock Appreciation Rights granted on 3/29/2011, which vested 50% each on 3/29/2014 and 3/29/2015.